Your browser doesn't support javascript.
SARS-CoV-2 vaccines in patients with SLE.
Tang, Wei; Askanase, Anca D; Khalili, Leila; Merrill, Joan T.
  • Tang W; Rheumatology, Columbia University Irving Medical Center, New York, New York, USA.
  • Askanase AD; Rheumatology, Columbia University Irving Medical Center, New York, New York, USA ada20@cumc.columbia.edu.
  • Khalili L; Rheumatology, Columbia University Irving Medical Center, New York, New York, USA.
  • Merrill JT; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation Arthritis and Clinical Immunology Research Program, Oklahoma City, Oklahoma, USA.
Lupus Sci Med ; 8(1)2021 03.
Article in English | MEDLINE | ID: covidwho-1123613
ABSTRACT
As the Moderna (mRNA-1273) and Pfizer/BioNTech (BNT162b2) vaccines become available to patients with autoimmune diseases and SLE, practitioners will have to inform them about the safety and efficacy of these vaccines. Here we discuss the challenges of applying vaccine data to patients with autoimmune diseases and the evidence available in the literature that may help in the decision process.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 / Lupus Erythematosus, Systemic Topics: Long Covid / Vaccines Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Lupus-2021-000479

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 / Lupus Erythematosus, Systemic Topics: Long Covid / Vaccines Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Lupus-2021-000479